Dihydropyrimidines sustain aggressive cancer states by stabilizing DPYSL2
Arata Hayashi, Sarah Knapp, Abdelrahaman Karmi…·Yoav David Shaul
This study identifies dihydropyrimidines (DHPs) as signaling metabolites that sustain aggressive cancer states by stabilizing DPYSL2, linking metabolic activity to oncogenic signaling.